NIHON PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 1921-08-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nihon-pharm.co.jp
Clinical Trials
22
Active:0
Completed:20
Trial Phases
3 Phases
Phase 1:1
Phase 2:5
Phase 3:15
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Phase 3
15 (71.4%)Phase 2
5 (23.8%)Phase 1
1 (4.8%)Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2022-12-01
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT05177939
- Locations
- 🇯🇵
Trial site 1, Ube, Yamaguchi, Japan
Study of NPO-13 During Colonoscopy
Phase 2
Completed
- Conditions
- Bowel Disease
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 158
- Registration Number
- NCT04097574
- Locations
- 🇯🇵
NPO-13 Trial Site 11, Kitakyushu, Fukuoka, Japan
🇯🇵NPO-13 Trial Site 12, Kurume, Fukuoka, Japan
🇯🇵NPO-13 Trial Site 2, Maebashi, Gunma, Japan
Study of NPF-08 in Patients Who Receive Colonoscopy
Phase 3
Completed
- Conditions
- Patients Who Receive Colonoscopy
- Interventions
- Drug: NPF-08 （2-day split dose）Drug: Moviprep（1-day treatment）Drug: NPF-08 （1-day treatment）
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 632
- Registration Number
- NCT03794310
- Locations
- 🇯🇵
NPF-08 Trial Site 12, Abiko, Chiba, Japan
🇯🇵NPF-08 Trial Site 11, Kashiwa, Chiba, Japan
🇯🇵NPF-08 Trial Site 1, Maebashi, Gunnma, Japan
Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: NPF-08
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT03423771
- Locations
- 🇯🇵
Osaka, Osaka, Japan
Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy
Phase 3
Completed
- Conditions
- Patients Undergoing Gastrointestinal Endoscopy
- Interventions
- Drug: NPO-11Drug: Placebo
- First Posted Date
- 2017-08-28
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Nihon Pharmaceutical Co., Ltd
- Target Recruit Count
- 220
- Registration Number
- NCT03263910
- Locations
- 🇨🇳
East China, East China, China
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found